Physician
Family Medicine
Dr. Tae H. Jung, MD
|
|
Give Review
Jung practices Family Medicine. He researched medicine at Wayne State University School of Medicine. Wayne State University School of Medicine has a rank of 63 in research and a 85 in primary care Jung is a published doctor and has 61 publications published. The lastest was: 'AKT1 polymorphisms and survival of early stage non-small cell lung cancer.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- AKT1 polymorphisms and survival of early stage non-small cell lung cancer.
- Performance of whole-blood interferon-gamma release assay in patients admitted to the emergency department with pulmonary infiltrates.
- Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers.
- Polymorphisms in apoptosis-related genes and survival of patients with early-stage non-small-cell lung cancer.
- Association of a common AGO1 variant with lung cancer risk: a two-stage case-control study.
- Polymorphisms in the caspase genes and the risk of lung cancer.
- The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia.
- LKB1 mutations are extremely rare in Korean non-small cell lung cancers.
- Polymorphisms in telomere maintenance genes and risk of lung cancer.
- Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
- Aberrant methylation of ADAMTS1 in non-small cell lung cancer.
- SLC11A1 polymorphisms are associated with the risk of chronic obstructive pulmonary disease in a Korean population.
- Identification of polymorphisms in the Caspase-3 gene and their association with lung cancer risk.
- Identification of polymorphisms in the XIAP gene and analysis of association with lung cancer risk in a Korean population.
- EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
- Combined effects of p73 and MDM2 polymorphisms on the risk of lung cancer.
- No association between p73 G4C14-to-A4T14 polymorphism and the risk of lung cancer in a Korean population.
- Collagen-based co-culture for invasive study on cancer cells-fibroblasts interaction.
- Polymorphisms in the hMSH2 gene and the risk of primary lung cancer.
- Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
- XPC polymorphisms and lung cancer risk.
- No association between polymorphisms in the histone deacetylase genes and the risk of lung cancer.
- Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer.
- -93G-->A polymorphism of hMLH1 and risk of primary lung cancer.
- No association between haplotypes of three variants (codon 81, 284, and 762) in poly(ADP-ribose) polymerase gene and risk of primary lung cancer.
- Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and risk of primary lung cancer.
- Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer.
- Myeloperoxidase -463G>A polymorphism and risk of primary lung cancer in a Korean population.
- Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study.
- DNMT3B polymorphisms and risk of primary lung cancer.
- Adjunctive effects of cyclosporine and macrolide in rapidly progressive cryptogenic organizing pneumonia with no prompt response to steroid.
- Polymorphisms in TGF-beta1 gene and the risk of lung cancer.
- Aberrant DNA methylation profiles of non-small cell lung cancers in a Korean population.
- Lys751Gln polymorphism in the DNA repair gene XPD and risk of primary lung cancer.
- Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean population.
- Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer.
- Isolated smoke inhalation injuries: acute respiratory dysfunction, clinical outcomes, and short-term evolution of pulmonary functions with the effects of steroids.
- Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study.
- Factors influencing residual pleural opacity in tuberculous pleural effusion.
- Polymorphisms in interleukin-1B and its receptor antagonist genes and the risk of chronic obstructive pulmonary disease in a Korean population: a case-control study.
- PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers.
- Clinical characteristics of patients with peripheral pulmonary embolism.
- TP53 mutations in Korean patients with non-small cell lung cancer.
- Telomere length and the risk of lung cancer.
- Septic pulmonary embolism in Korea: Microbiology, clinicoradiologic features, and treatment outcome.
- Mycoplasma pneumoniae bronchiolitis in adults: clinicoradiologic features and clinical course.
- SERPINE2 polymorphisms and chronic obstructive pulmonary disease.
- Dual roles of a variable number of tandem repeat polymorphism in the TERT gene in lung cancer.
- Polymorphisms in the survivin gene and the risk of lung cancer.
- MDR1 polymorphisms predict the response to etoposide-cisplatin combination chemotherapy in small cell lung cancer.
- Bacterial pneumonia following cytotoxic chemotherapy for lung cancer: clinical features, treatment outcome and prognostic factors.
- +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer.
- Comprehensive assessment of P21 polymorphisms and lung cancer risk.
- Polymorphisms in matrix metalloproteinase-1, -9 and -12 genes and the risk of chronic obstructive pulmonary disease in a Korean population.
- Polymorphisms in the Caspase7 gene and the risk of lung cancer.
- Caspase 9 promoter polymorphisms and risk of primary lung cancer.
- Venous thromboembolism in Korean patients undergoing major orthopedic surgery: a prospective observational study using computed tomographic (CT) pulmonary angiography ...
- Clinical course of pulmonary embolism in lung cancer patients.
- Glu346Lys polymorphism in the methyl-CpG binding domain 4 gene and the risk of primary lung cancer.
- Comprehensive analysis of DNA repair gene polymorphisms and survival in patients with early stage non-small-cell lung cancer.
Schools
Wayne State University
Akron Gen Med Center
Doctors Specialties
- Family Medicine
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Pathway X Tiered Hosp/Ind Direct Access OH
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- CareSource
- Cigna
- Commercial Insurance Company
- Coventry Health America PPO
- Emblem Health
- First Health (Coventry Health Care) PPO
- Golden Rule
- Medicare Advantage PFFS
- HealthSmart
- Choice Care PPO
- MedHealthInsurance
- Medicaid
- Medical Mutual of Ohio POS
- Medicare MCR
- Meritain Health
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- Principal Life
- Tricare
- UniCare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- UPMC Health Plan
- Wells Fargo Insurance
Education
-
Akron General Medical Center -
Wayne State University School of Medicine
Drug Facts
| NPI NUMBER | 1831153006 | |
| NPPES Provider LastName | JUNG | |
| NPPES Provider FirstName | TAE | |
| NPPES Provider ZIPCode | 439209200 | |
| NPPES Provider State | OH | |
| Specialty Description | Family Practice | |
| Total Claim Count | 2636.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 122.0 | |
| Percent Opioid Claims | 4.63 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1831153006 |
| Last Name Of The Provider | JUNG |
| First Name Of The Provider | TAE |
| View All |
Similar Doctors
|
|
Dr. Ghazanfar Ahmed, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tina M. Swarm, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph P. Sitarik, DO |
|
|
Dr. Lester H. Hill II, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ayman M. Fakeh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dharam B. Batish, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janet G. Marnejon, DO |
|
|
Dr. Rekha S. Parulkar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Jeffrey E. Jay, PT |